DCF — GRANVILLE MEDICAL CENTER
Enterprise Value: $-76.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-76.4M
Enterprise Value
$-25.4M
PV of Cash Flows
$-51.0M
PV of Terminal Value
$-82.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $83.9M | $-4.1M | -5.0% | $-7.7M | $-7.0M |
| Year 2 | $86.5M | $-3.4M | -4.0% | $-7.0M | $-5.8M |
| Year 3 | $89.1M | $-2.6M | -3.0% | $-6.3M | $-4.8M |
| Year 4 | $91.7M | $-2.2M | -2.0% | $-6.1M | $-4.1M |
| Year 5 | $94.5M | $-2.0M | -2.0% | $-6.0M | $-3.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-76.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$81.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.053825996937609394
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5